In this multi-center , 8-week , double-blind study , adults who had received 8 weeks of stable statin therapy and had hypertriglyceridemia ( TG level at 2.3-6 .5 mmol/L ) were randomized to receive CoA 400 U/d or placebo plus stable dosage of statin .